ALLO

ALLO

USD

Allogene Therapeutics Inc. Common Stock

$1.138-0.022 (-1.897%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.160

Hoch

$1.170

Tief

$1.130

Volumen

2.71M

Unternehmensfundamentaldaten

Marktkapitalisierung

252.5M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

3.36M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $0.86Aktuell $1.138Hoch $3.78

Ähnliche Nachrichten

GlobeNewswire

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™)

Mehr anzeigen
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
GlobeNewswire

Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for November 6, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage

Mehr anzeigen
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update